Matinas BioPharma Holdings Inc MTNB:NYSE American

Last Price$0.80Cboe Previous Close - Real-Time Last Sale as of 2:26PM ET 6/29/22
Cboe Real-Time Quotes
Today's Change-0.01(1.22%)
Bid (Size)$0.79 (1,000)
Ask (Size)$0.80 (2)
Day Low / High$0.80 - 0.82
Volume11.2 K

Matinas BioPharma Holdings Posts Flat Q4 Net Loss

6:55AM ET 3/08/2022 MT Newswires
Matinas BioPharma Holdings (MTNB) reported a Q4 net loss Tuesday of $0.03 per diluted share, unchanged from a year earlier.

Analysts polled by Capital IQ expected a loss of $0.04 per share.

The company did not record any revenue for the quarter ended Dec. 31, compared with $62,500 a year ago.

At the end of December, Matinas said it had cash, cash equivalents and marketable securities of about $49.6 million, down from $58.7 million a year earlier, which it expects will be sufficient to fund planned operations through 2023.

Price: 0.54, Change: -0.01, Percent Change: -1.82